For the year ending 2025-12-31, ABUS has $94,618K in assets. $18,042K in debts. $18,008K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 18,008 | |||
| Investments in marketable securities, current | 73,463 | |||
| Accounts receivable | 1,447 | |||
| Prepaid expenses and other current assets | 1,538 | |||
| Total current assets | 94,456 | |||
| Property and equipment, net of accumulated depreciation and impairment | 32 | |||
| Right of use asset | 0 | |||
| Other non-current assets | 130 | |||
| Total assets | 94,618 | |||
| Accounts payable and accrued liabilities | 5,459 | |||
| Deferred license revenue, current | 0 | |||
| Lease liability, current | 547 | |||
| Total current liabilities | 6,006 | |||
| Liability related to sale of future royalties | 3,442 | |||
| Deferred license revenue, non-current | 0 | |||
| Contingent consideration | 8,395 | |||
| Lease liability, non-current | 199 | |||
| Total liabilities | 18,042 | |||
| Issued and outstanding 192,531,225 and 189,963,492 as of december31, 2025 and 2024, respectively | 1,421,429 | |||
| Additional paid-in capital | 83,318 | |||
| Deficit | -1,380,073 | |||
| Accumulated other comprehensive loss | -48,098 | |||
| Total stockholders' equity | 76,576 | |||
| Total liabilities and stockholders' equity | 94,618 | |||
Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (ABUS)